Global Endometriosis Drugs Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

Global Endometriosis Drugs Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

  • SKU :
    SAC1306904
  • Published Date :
    May 31, 2024
  • Number of Pages :
    350

Product Description

The Endometriosis Drugs market was valued at US$ xx in 2023. The market for Endometriosis Drugs is projected to grow from US$ xx million in 2024, and is projected to reach xx by 2031, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Endometriosis Drugs industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Endometriosis Drugs by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Endometriosis Drugs market are discussed.

The market is segmented by types: 
    Hormonal Therapy
    Add-back Medication
    Progestogens
    Chinese Herbs

It can be also divided by applications:
    Hospitals
    Clinics
    Research Institutes

And this report covers the historical situation, present status and the future prospects of the global Endometriosis Drugs market for 2021-2031. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.
    AbbVie
    Astellas Pharma
    AstraZeneca
    Debiopharm Group
    Evotec AG
    Kissei Pharmaceutical
    Neurocrine Biosciences
    ObsEva
    Pfizer
    Repros Therapeutics
    Roivant Sciences GmbH
    Takeda Pharmaceutical Company Limited
    ValiRx

Report Includes:
- xx data tables and xx additional tables
- An overview of global Endometriosis Drugs market
- An detailed key players analysis across regions
- Analyses of global market trends, with historical data, estimates for 2024 and projections of compound annual growth rates (CAGRs) through 2031
- Insights into regulatory and environmental developments
- Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Endometriosis Drugs market
- Profiles of major players in the industry, including     AbbVie,     Astellas Pharma,     AstraZeneca,     Debiopharm Group,     Evotec AG.....

Research objectives
    To study and analyze the global Endometriosis Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2019 to 2021, and Forecast to 2031.
    To understand the structure of Endometriosis Drugs market by identifying its various subsegments.
    Focuses on the key global Endometriosis Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
    To analyze the Endometriosis Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To project the consumption of Endometriosis Drugs submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Content 

Table of Contents

Global Endometriosis Drugs Market Report 2024, Forecast to 2031

1 Scope of the Study
    1.1 Endometriosis Drugs Introduction
    1.2 Research Programs
    1.3 Analysis of Macroeconomic Indicators
    1.4 Years Considered
    1.5 Methodology
    1.6 Data Source
    1.7 Research Objectives

2 Endometriosis Drugs Industry Overview
    2.1 Global Endometriosis Drugs Market Size (Million USD) Comparison by Regions (2024-2031)
        2.1.1 Endometriosis Drugs Global Import Market Analysis
        2.1.2 Endometriosis Drugs Global Export Market Analysis
        2.1.3 Endometriosis Drugs Global Main Region Market Analysis
    2.2 Market Analysis by Type
        2.2.1 Hormonal Therapy
        2.2.2 Add-back Medication
        2.2.3 Progestogens
        2.2.4 Chinese Herbs
    2.3 Market Analysis by Application
        2.3.1 Hospitals
        2.3.2 Clinics
        2.3.3 Research Institutes
    2.4 Global Endometriosis Drugs Revenue, Sales and Market Share by Manufacturer
        2.4.1 Global Endometriosis Drugs Sales and Market Share by Manufacturer (2019-2023)
        2.4.2 Global Endometriosis Drugs Revenue and Market Share by Manufacturer (2019-2023)
        2.4.3 Global Endometriosis Drugs Industry Concentration Ratio (CR5 and HHI)
        2.4.4 Top 5 Endometriosis Drugs Manufacturer Market Share
        2.4.5 Top 10 Endometriosis Drugs Manufacturer Market Share
        2.4.6 Date of Key Manufacturers Enter into Endometriosis Drugs Market
        2.4.7 Key Manufacturers Endometriosis Drugs Product Offered
        2.4.8 Mergers & Acquisitions Planning
    2.5 Endometriosis Drugs Historical Development Overview
    2.6 Market Dynamics
        2.6.1 Market Opportunities
        2.6.2 Market Risk
        2.6.3 Market Driving Force
        2.6.4 Porter's Five Forces Analysis
    2.7 Coronavirus Disease 2019 (Covid-19): Endometriosis Drugs Industry Impact
        2.7.1 How the Covid-19 is Affecting the Endometriosis Drugs Industry
        2.7.2 Endometriosis Drugs Business Impact Assessment - Covid-19
        2.7.3 Market Trends and Endometriosis Drugs Potential Opportunities in the COVID-19 Landscape
        2.7.4 Measures / Proposal against Covid-19

3 Upstream and Downstream Market Analysis
    3.1 Upstream Analysis
        3.1.1 Macro Analysis of Upstream Markets
        3.1.2 Key Players in Upstream Markets
        3.1.3 Upstream Market Trend Analysis
        3.1.4 Endometriosis Drugs Manufacturing Cost Analysis
    3.2 Downstream Market Analysis
        3.2.1 Macro Analysis of Down Markets
        3.2.2 Key Players in Down Markets
        3.2.3 Downstream Market Trend Analysis
        3.2.4 Sales Channel, Distributors, Traders and Dealers

4 Global Endometriosis Drugs Market Size Categorized by Regions
    4.1 Global Endometriosis Drugs Revenue, Sales and Market Share by Regions
        4.1.1 Global Endometriosis Drugs Sales and Market Share by Regions (2019-2023)
        4.1.2 Global Endometriosis Drugs Revenue and Market Share by Regions (2019-2023)
    4.2 Europe Endometriosis Drugs Sales and Growth Rate (2019-2023)
    4.3 APAC Endometriosis Drugs Sales and Growth Rate (2019-2023)
    4.4 North America Endometriosis Drugs Sales and Growth Rate (2019-2023)
    4.5 South America Endometriosis Drugs Sales and Growth Rate (2019-2023)
    4.6 Middle East & Africa Endometriosis Drugs Sales and Growth Rate (2019-2023)

5 Europe Endometriosis Drugs Market Size Categorized by Countries
    5.1 Europe Endometriosis Drugs Sales, Revenue and Market Share by Countries
        5.1.1 Europe Endometriosis Drugs Sales by Countries (2019-2023)
        5.1.2 Europe Endometriosis Drugs Revenue by Countries (2019-2023)
        5.1.3 Germany Endometriosis Drugs Sales and Growth Rate (2019-2023)
        5.1.4 UK Endometriosis Drugs Sales and Growth Rate (2019-2023)
        5.1.5 France Endometriosis Drugs Sales and Growth Rate (2019-2023)
        5.1.6 Russia Endometriosis Drugs Sales and Growth Rate (2019-2023)
        5.1.7 Italy Endometriosis Drugs Sales and Growth Rate (2019-2023)
        5.1.8 Spain Endometriosis Drugs Sales and Growth Rate (2019-2023)
    5.2 Europe Endometriosis Drugs Revenue (Value) by Manufacturers (2019-2023)
    5.3 Europe Endometriosis Drugs Sales, Revenue and Market Share by Type (2019-2023)
        5.3.1 Europe Endometriosis Drugs Sales Market Share by Type (2019-2023)
        5.3.2 Europe Endometriosis Drugs Revenue and Revenue Share by Type (2019-2023)
    5.4 Europe Endometriosis Drugs Sales Market Share by Application (2019-2023)

6 Asia-Pacific Endometriosis Drugs Market Size Categorized by Countries
    6.1 Asia-Pacific Endometriosis Drugs Sales, Revenue and Market Share by Countries
        6.1.1 Asia-Pacific Endometriosis Drugs Sales by Countries (2019-2023)
        6.1.2 Asia-Pacific Endometriosis Drugs Revenue by Countries (2019-2023)
        6.1.3 China Endometriosis Drugs Sales and Growth Rate (2019-2023)
        6.1.4 Japan Endometriosis Drugs Sales and Growth Rate (2019-2023)
        6.1.5 Korea Endometriosis Drugs Sales and Growth Rate (2019-2023)
        6.1.6 India Endometriosis Drugs Sales and Growth Rate (2019-2023)
        6.1.7 Southeast Asia Endometriosis Drugs Sales and Growth Rate (2019-2023)
        6.1.8 Australia Endometriosis Drugs Sales and Growth Rate (2019-2023)
    6.2 Asia-Pacific Endometriosis Drugs Sales and Revenue (Value) by Manufacturers (2019-2023)
    6.3 Asia-Pacific Endometriosis Drugs Sales, Revenue and Market Share by Type (2019-2023)
        6.3.1 Asia-Pacific Endometriosis Drugs Sales Market Share by Type (2019-2023)
        6.3.2 Asia-Pacific Endometriosis Drugs Revenue and Revenue Share by Type (2019-2023)
    6.4 Asia-Pacific Endometriosis Drugs Sales and Market Share by Application (2019-2023)

7 North America Endometriosis Drugs Market Size Categorized by Countries
    7.1 North America Endometriosis Drugs Sales, Revenue and Market Share by Countries
        7.1.1 North America Endometriosis Drugs Sales by Countries (2019-2023)
        7.1.2 North America Endometriosis Drugs Revenue by Countries (2019-2023)
        7.1.3 United States Endometriosis Drugs Sales and Growth Rate (2019-2023)
        7.1.4 Canada Endometriosis Drugs Sales and Growth Rate (2019-2023)
        7.1.5 Mexico Endometriosis Drugs Sales and Growth Rate (2019-2023)
    7.2 North America Endometriosis Drugs Revenue (Value) by Manufacturers (2019-2023)
    7.3 North America Endometriosis Drugs Sales, Revenue and Market Share by Type (2019-2023)
        7.3.1 North America Endometriosis Drugs Sales Market Share by Type (2019-2023)
        7.3.2 North America Endometriosis Drugs Revenue and Revenue Share by Type (2019-2023)
    7.4 North America Endometriosis Drugs Sales Market Share by Application (2019-2023)

8 South America Endometriosis Drugs Market Size Categorized by Countries
    8.1 South America Endometriosis Drugs Sales, Revenue and Market Share by Countries
        8.1.1 South America Endometriosis Drugs Sales by Countries (2019-2023)
        8.1.2 South America Endometriosis Drugs Revenue by Countries (2019-2023)
        8.1.3 Brazil Endometriosis Drugs Sales and Growth Rate (2019-2023)
    8.2 South America Endometriosis Drugs Revenue (Value) by Manufacturers (2019-2023)
    8.3 South America Endometriosis Drugs Sales, Revenue and Market Share by Type (2019-2023)
        8.3.1 South America Endometriosis Drugs Sales Market Share by Type (2019-2023)
        8.3.2 South America Endometriosis Drugs Revenue and Revenue Share by Type (2019-2023)
    8.4 South America Endometriosis Drugs Sales Market Share by Application (2019-2023)

9 Middle East and Africa Endometriosis Drugs Market Size Categorized by Countries
    9.1 Middle East and Africa Endometriosis Drugs Sales, Revenue and Market Share by Countries
        9.1.1 Middle East and Africa Endometriosis Drugs Sales by Countries (2019-2023)
        9.1.2 Middle East and Africa Endometriosis Drugs Revenue by Countries (2019-2023)
        9.1.3 GCC Countries Endometriosis Drugs Sales and Growth Rate (2019-2023)
        9.1.4 Turkey Endometriosis Drugs Sales and Growth Rate (2019-2023)
        9.1.5 Egypt Endometriosis Drugs Sales and Growth Rate (2019-2023)
        9.1.6 South Africa Endometriosis Drugs Sales and Growth Rate (2019-2023)
    9.2 Middle East and Africa Endometriosis Drugs Revenue (Value) by Manufacturers (2019-2023)
    9.3 Middle East and Africa Endometriosis Drugs Sales, Revenue and Market Share by Type
        9.3.1 Middle East and Africa Endometriosis Drugs Sales Market Share by Type (2019-2023)
        9.3.2 Middle East and Africa Endometriosis Drugs Revenue and Revenue Share by Type (2019-2023)
    9.4 Middle East and Africa Endometriosis Drugs Sales Market Share by Application (2019-2023)

10 Global Endometriosis Drugs Market Segment by Type
    10.1 Global Endometriosis Drugs Revenue, Sales and Market Share by Type (2019-2023)
        10.1.1 Global Endometriosis Drugs Sales and Market Share by Type (2019-2023)
        10.1.2 Global Endometriosis Drugs Revenue and Market Share by Type (2019-2023)
    10.2 Hormonal Therapy Sales Growth Rate and Price
        10.2.1 Global Hormonal Therapy Sales Growth Rate (2019-2023)
        10.2.2 Global Hormonal Therapy Price (2019-2023)
    10.3 Add-back Medication Sales Growth Rate and Price
        10.3.1 Global Add-back Medication Sales Growth Rate (2019-2023)
        10.3.2 Global Add-back Medication Price (2019-2023)
    10.4 Progestogens Sales Growth Rate and Price
        10.4.1 Global Progestogens Sales Growth Rate (2019-2023)
        10.4.2 Global Progestogens Price (2019-2023)
    10.5 Chinese Herbs Sales Growth Rate and Price
        10.5.1 Global Chinese Herbs Sales Growth Rate (2019-2023)
        10.5.2 Global Chinese Herbs Price (2019-2023)

11 Global Endometriosis Drugs Market Segment by Application
    11.1 Global Endometriosis DrugsSales Market Share by Application (2019-2023)
    11.2 Hospitals Sales Growth Rate (2019-2023)
    11.3 Clinics Sales Growth Rate (2019-2023)
    11.4 Research Institutes Sales Growth Rate (2019-2023)

12 Market Forecast for Endometriosis Drugs
    12.1 Global Endometriosis Drugs Revenue, Sales and Growth Rate (2024-2031)
    12.2 Endometriosis Drugs Market Forecast by Regions (2024-2031)
        12.2.1 Europe Endometriosis Drugs Market Forecast (2024-2031)
        12.2.2 APAC Endometriosis Drugs Market Forecast (2024-2031)
        12.2.3 North America Endometriosis Drugs Market Forecast (2024-2031)
        12.2.4 South America Endometriosis Drugs Market Forecast (2024-2031)
        12.2.5 Middle East & Africa Endometriosis Drugs Market Forecast (2024-2031)
    12.3 Endometriosis Drugs Market Forecast by Type (2024-2031)
        12.3.1 Global Endometriosis Drugs Sales Forecast by Type (2024-2031)
        12.3.2 Global Endometriosis Drugs Market Share Forecast by Type (2024-2031)
    12.4 Endometriosis Drugs Market Forecast by Application (2024-2031)
        12.4.1 Global Endometriosis Drugs Sales Forecast by Application (2024-2031)
        12.4.2 Global Endometriosis Drugs Market Share Forecast by Application (2024-2031)

13 Analysis of Endometriosis Drugs Industry Key Manufacturers
    13.1 AbbVie
        13.1.1 Company Details
        13.1.2 Product Information
        13.1.3 AbbVie Endometriosis Drugs Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.1.4 Main Business Overview
        13.1.5 AbbVie News
    13.2 Astellas Pharma
        13.2.1 Company Details
        13.2.2 Product Information
        13.2.3 Astellas Pharma Endometriosis Drugs Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.2.4 Main Business Overview
        13.2.5 Astellas Pharma News
    13.3 AstraZeneca
        13.3.1 Company Details
        13.3.2 Product Information
        13.3.3 AstraZeneca Endometriosis Drugs Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.3.4 Main Business Overview
        13.3.5 AstraZeneca News
    13.4 Debiopharm Group
        13.4.1 Company Details
        13.4.2 Product Information
        13.4.3 Debiopharm Group Endometriosis Drugs Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.4.4 Main Business Overview
        13.4.5 Debiopharm Group News
    13.5 Evotec AG
        13.5.1 Company Details
        13.5.2 Product Information
        13.5.3 Evotec AG Endometriosis Drugs Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.5.4 Main Business Overview
        13.5.5 Evotec AG News
    13.6 Kissei Pharmaceutical
        13.6.1 Company Details
        13.6.2 Product Information
        13.6.3 Kissei Pharmaceutical Endometriosis Drugs Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.6.4 Main Business Overview
        13.6.5 Kissei Pharmaceutical News
    13.7 Neurocrine Biosciences
        13.7.1 Company Details
        13.7.2 Product Information
        13.7.3 Neurocrine Biosciences Endometriosis Drugs Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.7.4 Main Business Overview
        13.7.5 Neurocrine Biosciences News
    13.8 ObsEva
        13.8.1 Company Details
        13.8.2 Product Information
        13.8.3 ObsEva Endometriosis Drugs Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.8.4 Main Business Overview
        13.8.5 ObsEva News
    13.9 Pfizer
        13.9.1 Company Details
        13.9.2 Product Information
        13.9.3 Pfizer Endometriosis Drugs Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.9.4 Main Business Overview
        13.9.5 Pfizer News
    13.10 Repros Therapeutics
        13.10.1 Company Details
        13.10.2 Product Information
        13.10.3 Repros Therapeutics Endometriosis Drugs Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.10.4 Main Business Overview
        13.10.5 Repros Therapeutics News
    13.11 Roivant Sciences GmbH
        13.11.1 Company Details
        13.11.2 Product Information
        13.11.3 Roivant Sciences GmbH Endometriosis Drugs Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.11.4 Main Business Overview
        13.11.5 Roivant Sciences GmbH News
    13.12 Takeda Pharmaceutical Company Limited
        13.12.1 Company Details
        13.12.2 Product Information
        13.12.3 Takeda Pharmaceutical Company Limited Endometriosis Drugs Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.12.4 Main Business Overview
        13.12.5 Takeda Pharmaceutical Company Limited News
    13.13 ValiRx
        13.13.1 Company Details
        13.13.2 Product Information
        13.13.3 ValiRx Endometriosis Drugs Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.13.4 Main Business Overview
        13.13.5 ValiRx News

14 Research Findings and Conclusion

15 Appendix

Search results for Pharmaceutical Industry

Select License Type

get a sample
Ask For Customization
Get a quote
Speak to Analyst
Buy Now

Construction

Top Rated Products